Family CFO’s Amgen AMGN Stock Holding History

Family CFO’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-396	Closed	-$130K	–	45
2025 Q4	$130K	Buy	+396	New	+$126K	0.06%	46
2025 Q3	–	Sell	-500	Closed	-$140K	–	38
2025 Q2	$140K	Hold	500	–	–	0.07%	43
2025 Q1	$156K	Hold	500	–	–	0.09%	38
2024 Q4	$130K	Hold	500	–	–	0.07%	39
2024 Q3	$161K	Hold	500	–	–	0.09%	33
2024 Q2	$156K	Hold	500	–	–	0.1%	32
2024 Q1	$142K	Hold	500	–	–	0.09%	31
2023 Q4	$144K	Sell	500 -4	-0.8%	-$1.09K	0.09%	28
2023 Q3	$135K	Buy	504 +4	+0.8%	+$998	0.1%	29
2023 Q2	$111K	Hold	500	–	–	0.08%	32
2023 Q1	$121K	Hold	500	–	–	0.09%	30
2022 Q4	$131K	Hold	500	–	–	0.12%	26
2022 Q3	$113K	Hold	500	–	–	0.12%	26
2022 Q2	$122K	Hold	500	–	–	0.13%	26
2022 Q1	$121K	Hold	500	–	–	0.12%	28
2021 Q4	$112K	Buy	+500	New	+$106K	0.11%	30

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Family CFO's AMGN Position: Q1 2026 in Review

Family CFO sold out of Amgen (AMGN) in Q1 2026, closing a stake of 396 shares — an estimated $130K sold.

Family CFO first reported a position in AMGN in Q4 2021 and held it in 16 quarters. The position peaked at $161K in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Family CFO reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Family CFO sold 396 Amgen shares in Q1 2026, an estimated $130K.
Family CFO first reported a position in Amgen in Q4 2021 and held it in 16 quarters.
Family CFO's Amgen position peaked at $161K in Q3 2024.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Family CFO's 13F filing for Q1 2026, filed 28 Apr 2026.